# Epidemiologic Register on Diabetes and COVID-19 in Tunisia

> **NCT05603130** · — · COMPLETED · sponsor: **Les Laboratoires des Médicaments Stériles** · enrollment: 811 (actual)

## Conditions studied

- COVID-19 Disease

## Interventions

- **OTHER:** routinely collected clinical information

## Key facts

- **NCT ID:** NCT05603130
- **Lead sponsor:** Les Laboratoires des Médicaments Stériles
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-23
- **Primary completion:** 2022-06-30
- **Final completion:** 2022-10-17
- **Target enrollment:** 811 (ACTUAL)
- **Last updated:** 2022-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05603130

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05603130, "Epidemiologic Register on Diabetes and COVID-19 in Tunisia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05603130. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*